Peritoneal Dialysis Market to Reach USD 8.04 Billion by 2032

According to analysts at Vantage Market Research, the Global Genetic Engineering Market size is worth USD 4.8 Billion in 2023 and is projected to reach USD 8.04 Billion by 2032, growing at a CAGR (Compound Annual Growth Rate) of 5.91% from 2024 to 2032. Market drivers for the Peritoneal Dialysis includes the rising prevalence of chronic kidney disease, increasing patient preference for home-based dialysis, advancements in technology, and the need for more flexible treatment options.

Market Overview

The rising number of individuals suffering from renal disorders, such as kidney failure caused by conditions like cancer, trauma, diabetes, and aging, is expected to fuel market growth. Many benefits of peritoneal dialysis, such as needle-free therapy, increased mobility, convenience of use, reduced dietary restrictions, and cheaper than hemodialysis, all support the growth of the industry. Moreover, advancements in healthcare infrastructure, the growing choice for home-based dialysis, and the expanding need for affordable medical equipment are anticipated to fuel market growth.

Government initiatives, technological advancements, and awareness programs for chronic kidney disease (CKD) are key factors driving market growth. Health practitioners are increasingly favoring peritoneal dialysis over hemodialysis due to its cost-effectiveness, fewer symptom fluctuations, and greater patient mobility. The market is expanding due to the rising number of people suffering from renal failure as well as the introduction of new products such artificial kidneys and low-maintenance dialysis equipment.

Dialyss Pte Ltd was acquired by Nextkidney BV

• Dialyss Pte Ltd was acquired by Nextkidney BV, strengthening its technological capabilities in home hemodialysis

Key Takeaways from the Report

• In 2023, Asia Pacific dominated the market with 50.5% share. In region, market is driven by a high prevalence of hypertension and growing awareness campaigns about peritoneal dialysis
• By Treatment Type, the Continuous Ambulatory Peritoneal Dialysis (CAPD) accounted for significant market share of 59.2% in 2023. Segment’s growth is driven by the rising global patient population. 
• By Product, Peritoneal dialysis devices dominated the market with significant market share of 30.1%. Segment is driven by increasing demand for advanced and user-friendly dialysis equipment, particularly automated peritoneal dialysis (APD) devices

Top Companies

• Medtronic Plc
• Terumo Corporation
• Newsol Technologies Inc
• Renax Biomedical Tech. Co. Ltd
• Cook Medical Inc
• Utah Medical Products Inc
• Fresenius Medical Care AG & Co. KGaA
• Poly Medicure Ltd
• Medionics International Inc
• Baxter International Inc.

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events like the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.